Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer

NCT06059014 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

NCT01876771 ·Status: RECRUITING ·Phase: PHASE2

De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck

NCT06030440 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

NCT04029428 ·Status: UNKNOWN ·Phase: PHASE2

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

NCT02484339 ·Status: UNKNOWN ·Phase: PHASE2

Detection of Circulating Biomarkers of Immunogenic Cell Death

NCT02921854 ·Status: COMPLETED ·Phase: NA

Biomarker Identification of Radionuclide Therapy-induced Radiation Responses

NCT05513469 ·Status: UNKNOWN ·Phase: NA

A Phase 1 Study of [225Ac]-FPI-1434 Injection

NCT03746431 ·Status: TERMINATED ·Phase: PHASE1

A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

NCT02454010 ·Status: COMPLETED ·Phase: PHASE1

Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial

NCT03077854 ·Status: UNKNOWN ·Phase: NA

An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours

NCT02236910 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer

NCT02313298 ·Status: UNKNOWN ·Phase: PHASE2

Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer

NCT01812486 ·Status: COMPLETED ·Phase: PHASE3

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

NCT04665739 ·Status: RECRUITING ·Phase: PHASE2

Breathing Adapted Radiotherapy for Mediastinal Lymphoma

NCT00928096 ·Status: COMPLETED

Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer

NCT02048254 ·Status: UNKNOWN ·Phase: PHASE3

Actinium Therapy for Late-stage Aggressive Sarcomas

NCT07156565 ·Status: RECRUITING ·Phase: PHASE1

Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer

NCT04110249 ·Status: TERMINATED ·Phase: NA

Stereotactic Volumetric Radiotherapy in Prostate Cancer

NCT02423889 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

NCT02149602 ·Status: COMPLETED

Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer

NCT04452032 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Adaptive Radiotherapy in Head and Neck Tumor Patients

NCT06216171 ·Status: RECRUITING ·Phase: NA

Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI

NCT05302817 ·Status: TERMINATED ·Phase: PHASE1

HS-PCI in Locally Advanced Adenocarcinoma of the Lung

NCT02341170 ·Status: WITHDRAWN ·Phase: NA

Short Course Of Preoperative Radiotherapy in Head and Neck-, Trunk- and Extremity Soft Tissue Sarcomas

NCT04425967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA